Company Overview of Ensemble Therapeutics Corporation
Ensemble Therapeutics Corporation develops and markets macrocycle therapeutics to the pharmaceutical industry. The company offers Ensemblins, a macrocycle drug to treat diseases by addressing drug targets, such as protein-protein interactions, phosphatases, and proteases; and Interleukin-17, a pro-inflammatory cytokine for the treatment of multiple inflammatory and autoimmune diseases, such as psoriasis, rheumatoid arthritis, Crohn’s, and intestinal bowel disease. The company’s products are used to treat cancer and autoimmune diseases, neurology, metabolic disease, infectious diseases, and diabetes. Ensemble Therapeutics Corporation has strategic alliance with Bristol-Myers Squibb; and Novar...
99 Erie Street
Cambridge, MA 02139-4535
Founded in 2002
Key Executives for Ensemble Therapeutics Corporation
Founding Scientist and Member of the Scientific Advisory Board
Senior Director of Finance & Administration
Senior Vice President of Biology
Vice President of Screening & Biochemistry
Compensation as of Fiscal Year 2015.
Ensemble Therapeutics Corporation Key Developments
Ensemble Therapeutics Corporation Presents at BIO-Europe 2015, Nov-02-2015
Oct 1 15
Ensemble Therapeutics Corporation Presents at BIO-Europe 2015, Nov-02-2015 . Venue: Munich, Germany.
Ensemble Therapeutics Corporation Presents at EBD Group's Biopharm America 2014 Conference, Sep-22-2014
Sep 10 14
Ensemble Therapeutics Corporation Presents at EBD Group's Biopharm America 2014 Conference, Sep-22-2014 . Venue: Boston Marriott Copley Place, 110 Huntington Avenue, Boston, MA 02116, United States.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries